LYNPARZA (olaparib)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · EPITHELIAL OVARIAN CANCER ·+5
AstraZeneca Pharmaceuticals
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
TALZENNA (talazoparib tosylate)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH HRR GENE MUTATION ·+1
Parke-Davis Pfizer
ZEJULA (niraparib tosylate)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · EPITHELIAL OVARIAN CANCER WITH BRCA MUTATION ·+1
GSK
AKEEGA (niraparib tosylate/abiraterone acetate)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH BRCA MUTATION ·+1
JANSSEN BIOTECH, Inc.
TALZENNA (talazoparib tosylate)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH HRR GENE MUTATION ·+1
Laboratories Div
RUBRACA (rucaparib camsylate)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · EPITHELIAL OVARIAN CANCER WITH BRCA MUTATION ·+1
ZR PHARMA& GMBH